[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:heritable-pulmonary-arterial-hypertension":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":29,"states":30},"Heritable Pulmonary Arterial Hypertension",3,2,[8,15,21],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT05462574","Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)",[],"RECRUITING","2026-08-26T02:17:48.768272Z","2026-05-13T02:55:06.350126Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT01884051","Hormonal, Metabolic, and Signaling Interactions in PAH",[],"2026-08-26T02:18:00.873391Z","2026-05-13T02:55:06.080964Z",{"nct_id":22,"title":23,"phases":24,"status":26,"updated_at":27,"content_modified":28},"NCT03683186","A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension",[25],"Phase 3","ENROLLING_BY_INVITATION","2026-08-26T02:18:24.494016Z","2026-06-16T05:54:07.969216Z",[],[31],{"state":32,"count":5,"slug":33},"Tennessee","tennessee"]